Cowealth Medical Holding (4745) Fair Value & Analysis
Healthcare · TW · Market cap 1,000M TWD
Fair value as of: Jul 11, 2026
From 8 valuation models · updated today
Fair value updated Jul 11, 2026 — revised from 195.04 TWD to 14.28 TWD (−92.7%) since Jun 24, 2026. Share price −7.0% over the past month.
Price vs Fair Value (12 months)
12‑month range 13.70 TWD – 26.85 TWD · fair‑value band 14.23 TWD – 14.35 TWD · the 14.60 TWD price screens above the 14.28 TWD fair value. As of Jul 11, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Cowealth Medical Holding (4745) currently trades at 14.60 TWD, while our model-based Fair Value estimate is 14.28 TWD — implying the stock looks roughly 2.2% overvalued today. We read business quality at 36/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, Cowealth Medical Holding generated revenue of 2.9B TWD at a net margin of -8.6%. Revenue declined 11.6% year over year. It earns a return on equity of -6.5%. Net debt stands at 60.9M TWD. Fundamentals as of Jul 11, 2026
Our scenario range runs from 14.23 TWD (bear case) to 14.35 TWD (bull case); at 14.60 TWD, the current price sits above that range. The share trades about 47% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -29% fair-value upside — at -2%, 4745 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 11, 2026. TTM = trailing twelve months.
About the company
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision making, multi-channel coaxial-time-audio-video-image digital platform for operating rooms, and cross-trait medical resource platform. In addition, it provides equipment comprising CyberKnife Stereotactic Radiosurgery System, a non-invasive treatment alternative for cancerous and non-cancerous tumors, as well as other medical conditions requiring radiation therapy; LipiView Ocular Surface Interferometer and LipiView Thermal Pulsation System, a system designed to diagnose and address meibomian gland dysfunction; and MRIdian-Linac, an MRI-guided radiation therapy system. Further, the company is …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Cowealth Medical Holding reported revenue of 3.0B TWD in FY2025 versus 5.1B TWD in FY2021, a compound −12.9%/yr. Reported net income was −247M TWD in FY2025.
Is 4745 fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | 1,600 MXN | 82.40 MXN | -95% |
| Stryker Corporation S1YK34 | R$79.21 | R$43.74 | -45% |
| Medtronic plc MDT | $79.27 | $73.33 | -7% |
| Boston Scientific Corporation B1SX34 | R$229.30 | R$43.33 | -81% |
| Edwards Lifesciences Corporation EW | $85.98 | $41.02 | -52% |
| Siemens Healthineers AG SEMHF | $40.29 | $47.96 | +19% |
| GE HealthCare Technologies Inc GEHC | $63.76 | $44.97 | -29% |
| DexCom, Inc DXCM | $69.07 | $65.56 | -5% |
| Koninklijke Philips N.V 1PHIA | €24.31 | €9.97 | -59% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥141.85 | ¥147.63 | +4% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Cowealth Medical Holding (4745) undervalued?
What is the fair value of 4745?
What is the quality score of 4745?
What is the revenue of Cowealth Medical Holding (4745)?
What is the net profit margin of 4745?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
The 25 strongest value stocks, free every month
Enter your email to get the free monthly Top-25 report of the most undervalued quality stocks from 35,000+ analysed. Unsubscribe anytime.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.